Specifications
- Purity
- ≥30% (HPLC Silybin)
- Appearance
- Yellow to brown powder
- Identity
- 1H-NMR
Properties
- Solvents
- DMSO, ethanol (1 mg/ml)
Documentation
- Safety Data Sheet (SDS)
- CDX S0289 MSDS.pdf
Available from stock
Silymarin
- SKU
- S0289
Category: Phytochemicals
- Synonyms
- Mixture of flavanonolderivates Silibinin, Isosilibinin, Silicristin and Silidianin.
- 65666-07-1
- CAS-Number
- n/a
- Molecular Formula
- n/a
- Molecular Weight
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
- Shipping
- AMBIENT
- Short Term Storage
- -20°C
- Long Term Storage
- -20°C
- Handling Advice
- Protect from light and moisture.
- Use / Stability
- Stable for at least 2 years after receipt when stored at -20°C.
- Hazard statements
- H315, H319, H335
- Precautionary statements
- P264, P280, P362+364, P261
- GHS Symbol
- GHS07
- Signal word
- Warning
- Transportation
- Not dangerous goods
- Description
- Silymarin is a polyphenolic flavonoid extracted from the seeds of Silybum marianum or milk thistle. Silymarin is an isomeric mixture of the flavonolignans silydianin, silychristin, silibinin [Silybin] and isosilybin. It has similar biological properties to its main component Silibinin, including potent antioxidant, anti-inflammatory, anticancer, antidiabetic, hepatoprotective, neuroprotective, cardioprotective, antiviral, antimicrobial and immunosuppressive activities.
- References
- (1) N. Skottova & V. Krecman, Physiol. Res. 47, 1 (1998) (Review) , (2) R.P. Singh & R. Agarwal, Antioxid. Redox Signal. 4, 655 (2002) (Review) , (3) S.K. Katiyar, Int. J. Oncol. 26, 169 (2005) (Review) , (4) K.E. Mayer, et al., J. Viral. Hepat. 12, 559 (2005) (Review) , (5) R. Agarwal, et al., Anticancer Res. 26, 4457 (2006) (Review) , (6) K. Ramasamy & R. Agarwal, Cancer Lett. 269, 352 (2008) (Review) , (7) M. Rafieian-Kopaie & H. Nasri, J. Renal Inj. Prev. 1, 3 (2012) (Review) , (8) S.J. Polyak, et al., Hepatology 57, 1262 (2013) (Review) , (9) A. Borah, et al., CNS Neurosci. Ther. 19, 847 (2013) (Review) , (10) P.F. Surai, Antioxidants 4, 204 (2015) (Review) , (11) L. Voroneanu, et al., J. Diabetes Res. 2016, 5147468 (2016) (Review) , (12) K.P. Devi, et al., Curr. Drug Targets 18, 1529 (2017) (Review) , (13) N. Esmaeil, et al., Int. Immunopharmacol. 50, 194 (2017) (Review) , (14) M. Vahabzadeh, et al., J. Sci. Food Agric. 98, 4816 (2018) (Review) , (15) T. Hosseinabadi, et al., Phytother. Res. 33, 2849 (2019) (Review)
Silymarin is a polyphenolic flavonoid extracted from the seeds of Silybum marianum or milk thistle. Silymarin is an isomeric mixture of the flavonolignans silydianin, silychristin, silibinin [Silybin] and isosilybin. It has similar biological properties to its main component Silibinin, including potent antioxidant, anti-inflammatory, anticancer, antidiabetic, hepatoprotective, neuroprotective, cardioprotective, antiviral, antimicrobial and immunosuppressive activities.
Additional information
| Synonyms | Mixture of flavanonolderivates Silibinin, Isosilibinin, Silicristin and Silidianin. |
|---|---|
| Purity | ≥30% (HPLC Silybin) |
| Appearance | Yellow to brown powder |
| CAS-Number | 65666-07-1 |
| Molecular Formula | n/a |
| Molecular Weight | n/a |
| Identity | 1H-NMR |
| Solvents | DMSO, ethanol (1 mg/ml) |
| Shipping | AMBIENT |
| Short Term Storage | -20°C |
| Long Term Storage | -20°C |
| Handling Advice | Protect from light and moisture. |
| Use / Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Hazard statements | H315, H319, H335 |
| Precautionary statements | P264, P280, P362+364, P261 |
| GHS Symbol | GHS07 |
| Signal word | Warning |
| Transportation | Not dangerous goods |
| References | (1) N. Skottova & V. Krecman, Physiol. Res. 47, 1 (1998) (Review), (2) R.P. Singh & R. Agarwal, Antioxid. Redox Signal. 4, 655 (2002) (Review), (3) S.K. Katiyar, Int. J. Oncol. 26, 169 (2005) (Review), (4) K.E. Mayer, et al., J. Viral. Hepat. 12, 559 (2005) (Review), (5) R. Agarwal, et al., Anticancer Res. 26, 4457 (2006) (Review), (6) K. Ramasamy & R. Agarwal, Cancer Lett. 269, 352 (2008) (Review), (7) M. Rafieian-Kopaie & H. Nasri, J. Renal Inj. Prev. 1, 3 (2012) (Review), (8) S.J. Polyak, et al., Hepatology 57, 1262 (2013) (Review), (9) A. Borah, et al., CNS Neurosci. Ther. 19, 847 (2013) (Review), (10) P.F. Surai, Antioxidants 4, 204 (2015) (Review), (11) L. Voroneanu, et al., J. Diabetes Res. 2016, 5147468 (2016) (Review), (12) K.P. Devi, et al., Curr. Drug Targets 18, 1529 (2017) (Review), (13) N. Esmaeil, et al., Int. Immunopharmacol. 50, 194 (2017) (Review), (14) M. Vahabzadeh, et al., J. Sci. Food Agric. 98, 4816 (2018) (Review), (15) T. Hosseinabadi, et al., Phytother. Res. 33, 2849 (2019) (Review) |
| Quantity | 25 g, 50 g, 100 g, Bulk |
